TABLE 2.
NHEJ editing efficiency and embryo viability under multiple CRISPR-EZ conditions
| Gene | CRISPR-EZ conditions | Zygotes treated | Embryos survived to morula | Embryos assayed by RFLP | Editing |
||
|---|---|---|---|---|---|---|---|
| Bi-allelic | Partial | Unedited | |||||
| Tyr | 16 μm Cas9 RNPs, 1 ms | 29 | 8 (28%) | 8 | 1 (13%) | 7 (87%) | 0 |
| 16 μm Cas9 RNPs, 3 ms | 24 | 6 (25%) | 6 | 5 (83%) | 1 (17%) | 0 | |
| 16 μm Cas9 RNPs, 10 ms | 28 | 5 (18%) | 5 | 5 (100%) | 0 | 0 | |
| 8 μm Cas9 RNPs, 1 ms | 30 | 19 (63%) | 12 | 2 (16%) | 9 (75%) | 1 (8%) | |
| 8 μm Cas9 RNPs, 3 ms | 30 | 18 (60%) | 12 | 8 (67%) | 4 (33%) | 0 | |
| 8 μm Cas9 RNPs, 10 ms | 30 | 12 (40%) | 12 | 11 (92%) | 1 (8%) | 0 | |
| Cdh1 | 8 μm Cas9 RNPs, 3 ms | 35 | NDa | 25 | 0 | 14 (56%) | 11 (44%) |
| Cdk8 | 8 μm Cas9 RNPs, 3 ms | 35 | ND | 22 | 3 (14%) | 19 (86%) | 0 |
| Kif11 | 8 μm Cas9 RNPs, 3 ms | 35 | ND | 24 | 1 (4%) | 12 (50%) | 11 (46%) |
a ND means not determined.